Supporting the Australian Innovation Ecosystem with Dr Andrew Nash Artwork

Med Tech Talks Podcast

Robert Klupacs, CEO of the Bionics Institute, a world leader in medical device development, talks to leaders, investors, researchers and entrepreneurs in the med tech industry. He delves into their story, who and what motivated them along the way, and their advice to those following a similar path. He also explores the concept of innovation, and what it will take to improve the translation of innovation into commercialisation to change the lives of people living with challenging medical conditions.

All Episodes

Med Tech Talks Podcast

Supporting the Australian Innovation Ecosystem with Dr Andrew Nash

April 24, 2026 • Bionics Institute • Season 1 • Episode 41

0:00 | 30:17

In this latest episode of Med Tech Talks, Robert Klupacs is joined by Dr Andrew Nash, former CSO of CSL.

CSL is an Australian success story and one of the world’s leading biotechnology companies. CSL has a remarkable history spanning over a century, and a global reputation for developing and delivering life-saving medicines, particularly in immunology, haematology, and vaccines.

As Chief Scientific Officer, Andrew led CSL’s global research and early development strategy, playing a pivotal role in advancing innovative therapies from discovery through to clinical development, and ultimately to patients around the world.

Today, Andrew is a Director of: The Garvan Institute of Medical Research, the Burnet Institute, ASX listed Arovella, Jumar Incubator, Brandon Capital’s BioCatalyst and also part of the Bionics Institute’s own Industry Advisory Committee.

In this episode, you will learn from Andrew about:

Andrew's journey from academia to CSO of CSL
His thoughts on the opportunity for innovation in Australia
What Andrew would recommend to aspiring med tech and bio tech enterpreneurs to be successful

Learn more about Dr Andrew Nash

Learn more about CSL

Updated version 05/08/22

Robert Klupacs

Host